Scaphoid Non-union and Low-intensity Pulsed Ultrasound Trial
Launched by UNIVERSITY OF CALGARY · Mar 6, 2015
Trial Information
Current as of June 07, 2025
Unknown status
Keywords
ClinConnect Summary
This is a prospective, double-blind, multicentered, randomized controlled trial to determine the effectiveness of low-intensity pulsed ultrasound in decreasing the time to union of scaphoid non-unions after operative fixation as measured by serial CT scanning. Multiple centers across Canada will be involved in the study. Blinding will include patients, surgeons, research assistants, as well as all data handlers and analysts until trial completion or mid-term analysis. Baseline demographics including age, hand dominance, work status and medical co-morbidities of the patients will be collecte...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject has a scaphoid fracture \> 3 months-old with at least one feature of non-union including, collapse or humpback deformity, sclerosis at the fracture site or cystic changes evident on pre-operative diagnostic imaging
- • Subject has consented to surgical fixation at surgeon discretion
- • Subject is willing and has the ability to operate the LIPUS device for at least four to six months post-operatively
- Exclusion Criteria:
- • Subject with concomitant fracture or dislocation of another ipsilateral carpal bone, distal radius or ulna, or bilateral scaphoid fractures
- • Subject has an open or pathological fracture
- • Subject who are actively receiving treatment of a rheumatologic disorder with a biologic medication or other arthritic condition
- • Subject has a history of fibrous dysplasia, chronic renal failure, Paget's disease, osteopetrosis or other impairing disease/condition of the musculoskeletal system
- • Subject with an active infection of the affected limb
- • Subject with a high risk of death within the follow up period
- • Subject is a prisoner or at high risk of incarceration
- • Subject who are unlikely to complete follow-up (no fixed address, states they are unlikely to complete follow up, psychiatric condition at surgeon discretion)
- • Subject has cognitive impairment or language difficulties that would impede the completion of questionnaires
- • Subject who are pregnant or anticipate getting pregnant
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Vancouver, British Columbia, Canada
Montréal, Quebec, Canada
Calgary, Alberta, Canada
Winnipeg, Manitoba, Canada
Ottawa, Ontario, Canada
Patients applied
Trial Officials
Neil White, MD
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials